Quantitative assessment of muscle atrophy and structural changes in children with spinal muscular atrophy using ultrasound imaging
- PMID: 40394775
- DOI: 10.1016/j.ejpn.2025.04.013
Quantitative assessment of muscle atrophy and structural changes in children with spinal muscular atrophy using ultrasound imaging
Abstract
Background: Spinal muscular atrophy (SMA) in children is a hereditary neuromuscular disorder characterized by motor neuron degeneration, which leads to progressive muscle weakness and impaired movement. Ultrasound imaging, owing to its non-invasive, radiation-free, and cost-effective nature, provides an invaluable tool for visualizing muscle morphology. This technique offers a significant advantage in the clinical evaluation of SMA. The aim of this study was to quantitatively assess muscle abnormalities in children with SMA using both conventional ultrasound and shear wave elastography (SWE), and to explore the potential of these imaging modalities in the assessment of the disease.
Methods: A total of 20 patients with type II or III SMA, who had not received any prior disease-modifying treatment (DMT), were included in the SMA group. These patients were enrolled between May 2022 and January 2024. The control group comprised 20 healthy children matched for age and gender. Muscle thickness (MT) and shear wave velocity (SWV) of the biceps brachii (BB) and quadriceps femoris (QF) were measured using B-mode ultrasound and SWE. Ultrasound parameters were compared between children with SMA and healthy controls. Additionally, motor function in the SMA group was assessed using the Hammersmith Functional Motor Scale Expanded (HFMSE), and the correlation between ultrasound parameters and HFMSE scores was analyzed.
Results: The BB-MT, BB-SWV, QF-MT and QF-SWV in the SMA group, were significantly lower than those in the control group (p = 0.030, 0.000, 0.004, and 0.001, respectively). Correlation analysis revealed a significant positive correlation between QF-MT and QF-SWV in the SMA group and the HFMSE score (r = 0.802, p = 0.000; r = 0.56, p = 0.000, respectively).
Conclusions: Ultrasound imaging is an effective modality for detecting and quantifying muscle atrophy and structural changes in children with SMA. Moreover, it demonstrates a significant correlation with motor function, providing valuable insights into the clinical assessment of SMA.
Keywords: B-mode ultrasound; Motor function; Muscle thickness; Shear wave elastography; Spinal muscular atrophy.
Copyright © 2025 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
A Prospective Cohort Study on Quantitative Muscle Magnetic Resonance Imaging During the Treatment of Spinal Muscular Atrophy Types 2 and 3 in Children.Pediatr Neurol. 2025 Aug;169:98-104. doi: 10.1016/j.pediatrneurol.2025.05.006. Epub 2025 May 11. Pediatr Neurol. 2025. PMID: 40482302
-
Risdiplam treatment following onasemnogene abeparvovec in individuals with spinal muscular atrophy: a multicenter case series.BMC Neurol. 2025 Jul 7;25(1):283. doi: 10.1186/s12883-025-04276-4. BMC Neurol. 2025. PMID: 40624473 Free PMC article.
-
Drug treatment for spinal muscular atrophy types II and III.Cochrane Database Syst Rev. 2012 Apr 18;(4):CD006282. doi: 10.1002/14651858.CD006282.pub4. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2020 Jan 6;1:CD006282. doi: 10.1002/14651858.CD006282.pub5. PMID: 22513940 Updated.
-
Drug treatment for spinal muscular atrophy types II and III.Cochrane Database Syst Rev. 2011 Dec 7;(12):CD006282. doi: 10.1002/14651858.CD006282.pub3. Cochrane Database Syst Rev. 2011. Update in: Cochrane Database Syst Rev. 2012 Apr 18;(4):CD006282. doi: 10.1002/14651858.CD006282.pub4. PMID: 22161400 Updated.
-
Longitudinal Assessment of 4-Year HFMSE Changes in SMA II and III Patients Treated With Nusinersen.Eur J Neurol. 2025 Jul;32(7):e70268. doi: 10.1111/ene.70268. Eur J Neurol. 2025. PMID: 40576143 Free PMC article.
Cited by
-
Application of Biomarkers in Spinal Muscular Atrophy.Int J Mol Sci. 2025 Jul 17;26(14):6887. doi: 10.3390/ijms26146887. Int J Mol Sci. 2025. PMID: 40725131 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources